APP and Alzheimer disease: While HSP40 transfection into catecholaminergic a‐differentiated (CAD) cells decreased cellular levels of Abeta, it increased Abeta levels in hippocampal cultures, demonstrating a possible pathogenic role of HSP40 in AD (Carnini et al, 2012).